Clinical trials

Clinical studies represent an important part of the drug development process. They are an indispensable tool to determine the safety and efficacy of new drug candidates before they can be used to treat illness.

Clinical trials are used to evaluate potential treatments that have had some effect against disease in the lab, or in animal experiments. The whole point of a clinical trial is to find out if a treatment is effective.

Bayer is fully committed to publicly disclose information about its clinical trials in humans. Public disclosure of clinical trial information is done in line with the position of the global pharmaceutical industry associations laid down in the “Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases”.

The Bayer “Clinical Trials Registry and Results Database Website” ("this website") contains information on clinical trials sponsored by Bayer, and is provided for patients and healthcare professionals to increase the transparency of Bayer's clinical research.

If you would like to learn more about clinical trials we provide you with answers to frequently asked questions.

Randomized clinical trials are the trusted standard and a crucial step in securing a medicine’s regulatory approval. However, they do not tell us everything about the safety and efficacy of a treatment in daily clinical practice.